Results 171 to 180 of about 19,015 (246)

Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report. [PDF]

Lung Cancer (Auckl)
Lee ATM, Park CJ, Arter ZL, Nagasaka M, Ou SI.   +4 more
europepmc   +1 more source

Comparative Safety of GLP-1 Receptor Agonists Across Gastrointestinal, Renal and Pancreatic Systems. [PDF]

Pharmaceuticals (Basel)
Shokr H, Mekkawy M, Hindi A.
europepmc   +1 more source

De gustibus est disputandum: The role of agricultural and applied economists in an era of behavior change initiatives and endogenous preferences

American Journal of Agricultural Economics, Volume 108, Issue 2, Page 429-442, March 2026.
Abstract Popular society increasingly questions preferences that drive many resource allocations and production decisions, with many groups actively seeking to alter those preferences to achieve changes to resource use. Agricultural and applied economists, who are already equipped with excellent technical skills to undertake consumer preference and ...
Brian E. Roe
wiley   +1 more source

Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW. [PDF]

Cardiovasc Diabetol
Rossing P, Lindhardt M, Tikkanen CK, Menon J, Cattin J, Hunt B, Malkin SJP, Chubb B, Damgaard T, Borg R.   +9 more
europepmc   +1 more source

Comparing SGLT2i and Other Oral Antidiabetic Drugs as Dual Therapy Add‐On to Metformin in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
This systematic literature review and meta‐analysis compared sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2is) against other metformin‐containing oral dual‐therapies (ODTs) in type 2 diabetes mellitus. SGLT‐2i plus metformin exhibited overall comparable efficacy and safety, with a lower risk of hypoglycaemia and greater weight reduction than other ...
Yuhang Ma, Yi Lin, Xiaoying Ding, Yongde Peng   +3 more
wiley   +1 more source

Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation. [PDF]

Healthcare (Basel)
Whorton A, Osman S, Johal J, Baig S, Jones AM, Jalal Z.   +5 more
europepmc   +1 more source

Improvement of Analysis and Transferability in Peptide Purification: From HPLC to FPLC and Back Again

Journal of Peptide Science, Volume 32, Issue 3, March 2026.
A predictive workflow enables accurate transfer from analytical HPLC to preparative FPLC for peptide purification. Systematic evaluation of key chromatographic parameters identified particle size, flow optimization and modifier choice as critical for selectivity and resolution. A correction model minimized elution transfer errors from −17% to less than
Alessandro Streuli, Vanessa Erckes, Brunello Nardone, Vincent Bedard, François Beland, Christian Steuer   +5 more
wiley   +1 more source

Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney disease. [PDF]

World J Nephrol
Economos H, MacIsaac RJ.
europepmc   +1 more source

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis

British Journal of Pharmacology, Volume 183, Issue 5, Page 1030-1047, March 2026.
Background and Purpose Myocardial fibrosis (MF), a hallmark of structural cardiac remodelling, drives disease progression across most forms of heart failure and plays a central role in heart failure with preserved ejection fraction (HFpEF). Despite its clinical relevance, effective treatments remain scarce.
Sheyla Barrado‐Ballestero, Sarah Torp Yttergren, Max Hahn, Marie Biviano Rosenkilde, Ditte Marie Jensen, Michael Christensen, Louise Thisted, Heidi Lindgreen Holmberg, Geoffrey Teixeira, Tor Biering‐Sørensen, Casper Gravesen Salinas, Urmas Roostalu   +11 more
wiley   +1 more source

Once-Weekly Semaglutide Is Associated With Improvement in Vascular Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Retrospective Observational Study. [PDF]

Cureus
Sugiyama S, Yoshida A, Kurinami N, Hieshima K, Jinnouchi K, Suzuki T, Miyamoto F, Kajiwara K, Jinnouchi H.   +8 more
europepmc   +1 more source